Silvercrest Asset Management Group LLC
- SEC CIK
- 0001232395
- Latest filing
- Aug 14, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by Silvercrest Asset Management Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −10,429−100.0% | Sold out | Holders |
| Q1 2026 | 10,429 | $3.45M | <0.1% | +19+0.2% | Added | Holders |
| Q4 2025 | 10,410 | $4.14M | <0.1% | −397−3.7% | Reduced | Holders |
| Q3 2025 | 10,807 | $4.93M | <0.1% | +556+5.4% | Added | Holders |
| Q2 2025 | 10,251 | $3.34M | <0.1% | +430+4.4% | Added | Holders |
| Q1 2025 | 9,821 | $2.65M | <0.1% | +4,930+100.8% | Added | Holders |
| Q4 2024 | 4,891 | $1.15M | <0.1% | +4,891 | New | Holders |